← Genopetsreviewed 2026-09-05 · 49 claims checked
Fact-check findings
What an automated fact-checker found when it re-read Genopets against the sources the page cites. Only the most recent review is shown.
Read this first
These findings are produced by an automated reviewer, and its results vary between runs: the same page, checked three times on the same day, came back with 15%, 20% and 34% of its claims disputed, mostly because each run extracted a different number of claims. Treat what follows as leads, not rulings.
“Disputed” means the reviewer could not reconcile the claim with the evidence it cited. It does not mean the claim is false. “Unverifiable” means no reachable source settled it either way.
Nothing here changes the page on its own. A proposed correction is applied only after a human moderator approves it; until then the page reads as it did when reviewed.
disputed
4 claimsThe reviewer could not reconcile the claim with the evidence it cited. This is a lead, not a ruling that the claim is false.
- #2[disputed][awaiting moderator]in the summary
“The project raised $8.3 million in seed funding from reputable investors including Pantera Capital and Samsung Next, but its dual-token economy (GENE and KI) has suffered severe inflation-driven value collapse characteristic of the broader move-to-earn category.”
reviewerThe $8.3 million seed round investors are said to include both Pantera Capital and Samsung Next.The page's own Section 3 (Funding) correctly separates the October 2021 $8.3M seed round from Samsung Next's later, undisclosed July 2022 SAFT investment, but the summary conflates the two into a single '$8.3 million... including Pantera Capital and Samsung Next' statement, which is inaccurate.Proposed correction (not yet applied)The project raised $8.3 million in seed funding from reputable investors including Pantera Capital, with an additional 2022 investment from Samsung Next, but its dual-token economy (GENE and KI) has suffered severe inflation-driven value collapse characteristic of the broader move-to-earn category. - #31[disputed][awaiting moderator]in section: Project Activity and Strategic Pivot
“The 5 million GENE Lockdrop campaign ahead of ELITE's TGE was announced as a reward for existing GENE stakers.”
reviewerThe 5 million GENE Lockdrop campaign ahead of ELITE's TGE was announced as a reward for existing GENE stakers.The URL slug itself still reads '5m-dollargene-lockdrop' (likely never updated after the campaign amount was revised upward), but the live page title and content describe a 10 million GENE distribution, not 5 million. The page's figure is outdated/incorrect.Proposed correction (not yet applied)The 10 million GENE Lockdrop campaign ahead of ELITE's TGE was announced as a reward for existing GENE stakers. - #39[disputed][awaiting moderator]in the timeline
“2021-11-13”
reviewerThe GENE token public sale on Impossible Finance, Raydium, Bybit, and MEXC was conducted on November 13, 2021.Both independent reporting on the sale window and the cited source's own timestamp point to November 16-18, 2021, not November 13.Proposed correction (not yet applied)2021-11-18 - #47[disputed][awaiting moderator]in the timeline
“ELITE token TGE announced with 5M GENE Lockdrop.”
reviewerOn May 2, 2025 the Genopets Elite Agents MCP Marketplace entered beta, the project rebranded to 'WHITTAKR Agent Era', and the ELITE token TGE was announced with a 5M GENE Lockdrop.The MCP Marketplace beta / WHITTAKR rebrand date (May 2, 2025) is corroborated by the source tweet's own timestamp, but the Lockdrop figure bundled into the same timeline entry is incorrect — it should read 10M, not 5M, matching the same defect found in Section 5.Proposed correction (not yet applied)ELITE token TGE announced with 10M GENE Lockdrop.
unverifiable
4 claimsNo source the reviewer could reach confirms or contradicts the claim.
- #11[unverifiable][awaiting moderator]in section: Team Transparency and Founder Backgrounds
“The team is described as all Asian-American.”
reviewerThe team is described as all Asian-American.None of the cited sources or any source found during independent research characterizes the founding team's ethnicity; this appears to be an unsourced editorial inference rather than a fact drawn from the cited profiles. - #27[unverifiable][awaiting moderator]in section: Incidents and Security Record
“The team proactively warned users during the GENE public sale in November 2021 that only four official launchpads should be trusted and that no official team member would DM users unsolicited — a standard anti-phishing notice.”
reviewerDuring the November 2021 GENE public sale, the team warned users to trust only four official launchpads and that no team member would DM users unsolicited.Could not independently access the cited tweet's content due to platform-level access restrictions; the claim is plausible but unconfirmed. - #37[unverifiable][awaiting moderator]in the timeline
“Genopets whitepaper and project concept publicly announced.”
reviewerThe Genopets whitepaper and project concept were publicly announced in September 2021.The cited source does not actually support a September 2021 date; no independent source confirming this specific date was found. - #42[unverifiable][awaiting moderator]in the timeline
“KI token reaches its all-time high of approximately $0.3967.”
reviewerKI token reached its all-time high of approximately $0.3967 on August 12, 2022 (timeline entry).Plausible but not independently confirmed due to tooling limitations on this specific low-liquidity token's historical chart.
stale
2 claimsThe claim was accurate when written but events since have overtaken it.
- #48[stale][awaiting moderator]in the timeline
“2025-11-24”
reviewerGENE token reached an all-time low of approximately $0.001069 on November 24, 2025.A new, lower all-time low has been reached since this entry was recorded; the November 2025 figure is no longer the actual ATL.Proposed correction (not yet applied)2026-08-08 - #49[stale][awaiting moderator]in the timeline
“GENE token reaches all-time low of approximately $0.001069.”
reviewerGENE token's all-time-low value is approximately $0.001069.Companion finding to the date correction above; both the date and the dollar figure need updating to reflect the current all-time low.Proposed correction (not yet applied)GENE token reaches all-time low of approximately $0.0009417.
partially supported
4 claimsThe cited evidence supports part of the claim but not all of it.
- #16[partially supported][awaiting moderator]in section: Funding and Investor Backing
“Alameda's portfolio positions were liquidated as part of bankruptcy proceedings; however, no evidence has been identified that Alameda's involvement directly harmed Genopets beyond broader market confidence effects.”
reviewerAlameda's portfolio positions were liquidated in bankruptcy proceedings, with no evidence Alameda's involvement directly harmed Genopets beyond broader market confidence effects.The general Alameda-estate-liquidation fact is well documented, but the Genopets-specific claim ('no evidence... directly harmed Genopets') is a negative claim that is plausible but not independently confirmable from a source that discusses Genopets specifically. - #21[partially supported][awaiting moderator]in section: Tokenomics and Move-to-Earn Sustainability Risk
“KI reached an all-time high of approximately $0.3967 on August 12, 2022, and subsequently suffered near-total value collapse, with CoinGecko reporting that trading effectively ceased on all listed exchanges as of late 2025.”
reviewerKI reached an all-time high of approximately $0.3967 on August 12, 2022, and trading effectively ceased on all listed exchanges as of late 2025 per CoinGecko.The directional claim (near-total collapse, effective illiquidity) is well supported, but the precise ATH figure/date and the specific attribution of the 'ceased trading... late 2025' framing to CoinGecko could not be independently confirmed. - #36[partially supported][awaiting moderator]in the timeline
“Genopets founded by Albert Chen and Benjamin Tse on Solana.”
reviewerGenopets was founded by Albert Chen and Benjamin Tse on Solana in April 2021.The April 2021 date is supported by one founder's listed role-start date but conflicts with other aggregator data suggesting January or fall 2021; additionally, a third co-founder (Jay Chang) named in a cited-adjacent source is omitted from the page entirely. - #46[partially supported][awaiting moderator]in the timeline
“Genopets Public Beta V1 launches with Energy 2.0, redesigned onboarding, and revised in-game economy.”
reviewerGenopets Public Beta V1 launched on March 20, 2024 with Energy 2.0, redesigned onboarding, and revised in-game economy.General event and month confirmed; the specific day-level precision (March 20) is unverified.
confirmed
35 claimsThe cited evidence supports the claim as written.
- #1[confirmed][no action needed]in the summary
“Genopets is a Solana-based move-to-earn NFT game launched in 2021, self-described as the first free-to-play move-to-earn title in the space, operated by a named and publicly identifiable founding team.”
reviewerGenopets is a Solana-based move-to-earn NFT game launched in 2021, self-described as first free-to-play move-to-earn title, with a publicly identifiable founding team.Consistent with CoinDesk and multiple secondary sources; founders are publicly named. - #3[confirmed][no action needed]in the summary
“As of mid-2026 the team remains active, having pivoted toward AI-agent infrastructure under the 'ELITE/WHITTAKR' umbrella, though both tokens trade near all-time lows with minimal liquidity.”
reviewerAs of mid-2026 the team remains active with a pivot toward AI-agent infrastructure ('ELITE/WHITTAKR'), and both GENE and KI trade near all-time lows with minimal liquidity.GENE and KI both trade at a small fraction of peak value with negligible volume; the WHITTAKR/ELITE pivot is real and ongoing. - #4[confirmed][no action needed]in section: Background and Project Overview
“Genopets was founded in 2021 and describes itself as the world's first free-to-play, move-to-earn NFT game built on the Solana blockchain.”
reviewerGenopets was founded in 2021 and describes itself as the world's first free-to-play move-to-earn NFT game built on Solana.Confirmed self-description, widely repeated across secondary sources. - #5[confirmed][no action needed]in section: Background and Project Overview
“The governance and staking token is $GENE, capped at 100 million tokens.”
reviewerPlayers link a device/wearable; real-world steps convert to Energy used to evolve the Genopet NFT and harvest $KI; $GENE is the governance/staking token capped at 100 million.100M GENE cap independently corroborated by multiple tokenomics trackers. - #6[confirmed][no action needed]in section: Background and Project Overview
“The game officially entered public beta in March 2024 after extended private beta periods.”
reviewerThe game officially entered public beta in March 2024 after extended private beta periods.Matches official announcement title and timing. - #7[confirmed][no action needed]in section: Background and Project Overview
“In 2025 the project began a strategic expansion under the brand name 'WHITTAKR Agent Era,' pivoting toward no-code AI agent infrastructure via an 'ELITE' token and an MCP Marketplace described by the team as 'Shopify for AI Agents.'”
reviewerIn 2025 the project began an expansion under 'WHITTAKR Agent Era', pivoting to no-code AI agent infrastructure via an ELITE token and an MCP Marketplace described as 'Shopify for AI Agents.'The 'Shopify for AI Agents' phrase is a verbatim match to the team's own promotional language. - #8[confirmed][no action needed]in section: Team Transparency and Founder Backgrounds
“Albert Chen is Co-Founder and CEO/CTO; he holds a degree from the University of Michigan (2005–2009), has approximately 20 years of professional experience spanning e-commerce, growth marketing, and software development, and previously co-founded GeneOS (2018–2020), held a Chief Architect role at Arcana (2018–2019), founded UM! Brands (2011–2016), and co-founded masklab (2020).”
reviewerAlbert Chen is Co-Founder and CEO/CTO with University of Michigan degree (2005-2009), ~20 years experience, prior roles at GeneOS, Arcana, UM! Brands, masklab, and EOS Global Hackathon 2018 winner.Core biographical facts (UMich years, GeneOS, masklab, hackathon win) independently corroborated across multiple sources; exact Arcana title/UM! Brands years not independently confirmed beyond aggregator listings. - #9[confirmed][no action needed]in section: Team Transparency and Founder Backgrounds
“Benjamin Tse is Co-Founder and CPO; he has 15+ years in UI/UX and product design, founded Hundredfold Studios (2005–2021), was CPO at Arcana (2018–2020), and also won the EOS Global Hackathon in 2018.”
reviewerBenjamin Tse is Co-Founder and CPO with 15+ years in UI/UX and product design, founded Hundredfold Studios (2005-2021), was CPO at Arcana (2018-2020), and also won the EOS Global Hackathon in 2018.15+ years figure independently corroborated by Samsung Next's own investment blog post. - #10[confirmed][no action needed]in section: Team Transparency and Founder Backgrounds
“Both Chen and Tse held overlapping roles at Arcana prior to Genopets, indicating a pre-existing working relationship.”
reviewerBoth Chen and Tse held overlapping roles at Arcana prior to Genopets, indicating a pre-existing working relationship.Corroborated by third-party bio aggregators describing both as Arcana co-founders/partners. - #12[confirmed][no action needed]in section: Team Transparency and Founder Backgrounds
“No regulatory or legal actions have been identified against any named founder as of the investigation date.”
reviewerNo regulatory or legal actions have been identified against any named founder as of the investigation date.Absence-of-evidence claim; no contrary reporting found. - #13[confirmed][no action needed]in section: Funding and Investor Backing
“In October 2021 Genopets raised $8.3 million in a seed funding round co-led by Konvoy Ventures and Pantera Capital, with additional participation from Alameda Research, Solana Capital, Mechanism Capital, Animoca Brands, Xoogler Ventures, Old Fashion Research, GBV, and Eniac Ventures.”
reviewerIn October 2021 Genopets raised $8.3 million co-led by Konvoy Ventures and Pantera Capital, with Alameda Research, Solana Capital, Mechanism Capital, Animoca Brands, Xoogler Ventures, Old Fashion Research, GBV, and Eniac Ventures participating.Accurate, though the full investor list reported by some outlets is longer (includes Collab+Currency, Spartan Group, etc.) than the subset named on the page; this is a reasonable abridgment, not an error. - #14[confirmed][no action needed]in section: Funding and Investor Backing
“In July 2022 Samsung Next (the venture arm of Samsung Electronics) made an undisclosed additional investment through a Simple Agreement for Future Tokens (SAFT), citing the project's innovative model and experienced team.”
reviewerIn July 2022 Samsung Next made an undisclosed additional investment through a SAFT, citing the project's innovative model and experienced team.Confirmed; minor date variance (July 7 vs. July 8-12 in press pickups) is immaterial. - #15[confirmed][no action needed]in section: Funding and Investor Backing
“The Alameda Research investment carries a reputational caveat: Alameda was the trading subsidiary of FTX, which collapsed in November 2022 and was the subject of criminal fraud convictions against its founder.”
reviewerAlameda was FTX's trading subsidiary; FTX collapsed November 2022 and its founder faced criminal fraud convictions.Widely reported, uncontroversial fact. - #17[confirmed][no action needed]in section: Tokenomics and Move-to-Earn Sustainability Risk
“GENE token distribution at launch was approximately: Community Treasury 41%, Private Sale 32.5%, Team and Advisors 25%, and IDO 1.5%.”
reviewerGENE is capped at 100M with a governance/staking function; KI is an unbounded utility token minted through gameplay, with distribution Community Treasury 41%, Private Sale 32.5%, Team and Advisors 25%, IDO 1.5%.Exact match to independently-sourced tokenomics data. - #18[confirmed][no action needed]in section: Tokenomics and Move-to-Earn Sustainability Risk
“In December 2022, citing market conditions, a majority of SAFT holders, lead investors, and founders agreed to extend the vesting period by one additional year (to a 4-year schedule for founders), which the team publicly framed as a commitment signal.”
reviewerIn December 2022, a majority of SAFT holders, lead investors, and founders agreed to extend GENE vesting by one additional year, to a 4-year schedule for founders.Directly confirmed by the cited whitepaper page. - #19[confirmed][no action needed]in section: Tokenomics and Move-to-Earn Sustainability Risk
“GENE reached an all-time high of approximately $37.83 on November 30, 2021, shortly after its IDO.”
reviewerGENE reached an all-time high of approximately $37.83 on November 30, 2021.Exact match to current CoinGecko data. - #20[confirmed][no action needed]in section: Tokenomics and Move-to-Earn Sustainability Risk
“As of mid-2026 GENE trades around $0.0017, representing a decline of approximately 99.99% from peak.”
reviewerAs of mid-2026 GENE trades around $0.0017, a decline of approximately 99.99% from peak.Price is reasonably close to current levels given normal short-term volatility and the page's own hedge ('as of mid-2026'). - #22[confirmed][no action needed]in section: Tokenomics and Move-to-Earn Sustainability Risk
“In early 2024 the team published a 'Genopets Reborn' tokenomics revamp acknowledging structural problems including an 'unbounded mint model' for KI, Energy system exploits allowing step inflation, and the need to realign incentives.”
reviewerIn early 2024 the team published a 'Genopets Reborn' tokenomics revamp acknowledging an unbounded KI mint model, Energy system exploits, and the need to realign incentives.Directly confirmed. - #23[confirmed][no action needed]in section: Tokenomics and Move-to-Earn Sustainability Risk
“The revamp introduced Qubits (an in-game currency backed by GENE), Energy 2.0, and a Harvesting Rework.”
reviewerThe revamp introduced Qubits (an in-game currency backed by GENE), Energy 2.0, and a Harvesting Rework.Exact match to the official revamp announcement. - #24[confirmed][no action needed]in section: Tokenomics and Move-to-Earn Sustainability Risk
“The structural weaknesses in the KI model — unlimited supply driven by player step activity with insufficient burn sinks — mirror those seen in the collapse of STEPN's GST token in 2022, where daily earnings fell from approximately $42.55 to $0.06 and monthly active users declined from 700,000 to approximately 30,000 within one year.”
reviewerSTEPN's GST token collapse mirrors Genopets' KI problem: daily earnings fell from ~$42.55 to ~$0.06, and MAU declined from 700,000 to ~30,000 within one year.Both specific figures independently verified against the cited CoinGecko report and separate reporting on STEPN user decline. - #25[confirmed][no action needed]in section: Tokenomics and Move-to-Earn Sustainability Risk
“Genopets' whitepaper explicitly acknowledges the risks of overreliance on inflationary token emissions and proposes a player-to-player marketplace economy as a counterweight, but the actual market outcome for KI mirrors the wider category collapse.”
reviewerGenopets' whitepaper acknowledges risks of overreliance on inflationary token emissions and proposes a player-to-player marketplace economy as a counterweight.Directly confirmed by the cited whitepaper page. - #26[confirmed][no action needed]in section: Incidents and Security Record
“No confirmed hacks, exploits, or theft events specific to the Genopets protocol have been identified through available sources.”
reviewerNo confirmed hacks, exploits, or theft events specific to the Genopets protocol have been identified.Absence-of-evidence claim, consistent with independent research. - #28[confirmed][no action needed]in section: Incidents and Security Record
“Scam Detector assigned genopets.io a medium-high trust score (75.4) and flagged genopets.cc as controversial (42.5), indicating the existence of copycat or impersonation domains.”
reviewerScam Detector assigned genopets.io a medium-high trust score (75.4) and flagged genopets.cc as controversial (42.5).Both scores independently confirmed exactly as stated. - #29[confirmed][no action needed]in section: Incidents and Security Record
“No SEC, CFTC, DOJ, or other regulatory actions have been identified against Genopets, its founders, or its associated entities as of the investigation date.”
reviewerNo SEC, CFTC, DOJ, or other regulatory actions have been identified against Genopets, its founders, or its associated entities.Absence-of-evidence claim consistent with independent research. - #30[confirmed][no action needed]in section: Project Activity and Strategic Pivot
“In 2025 the team began a pronounced strategic pivot toward AI-agent infrastructure, rebranding the X/Twitter profile to 'Genopets — WHITTAKR Agent Era,' and introducing the ELITE token (TGE announced in 2025) intended to serve as a governance token for no-code AI utility agents on Solana.”
reviewerIn 2025 the team pivoted toward AI-agent infrastructure, rebranding X/Twitter to 'Genopets — WHITTAKR Agent Era' and introducing the ELITE token (TGE announced in 2025).Rebrand and ELITE token pivot independently confirmed. - #32[confirmed][no action needed]in section: Project Activity and Strategic Pivot
“A Pixelton Arena game for Telegram was also launched as a secondary product.”
reviewerA Pixelton Arena game for Telegram was also launched as a secondary product.Confirmed via multiple independent outlets covering the Telegram mini-app launch. - #33[confirmed][no action needed]in section: Game Quality and Community Reception
“Third-party game review site GAM3S.GG characterizes Genopets as 'more akin to a gamified fitness app than a full-fledged game,' noting an engaging art style and accessible setup process, but flagging a limited game loop and potential for repetitive gameplay.”
reviewerGAM3S.GG characterizes Genopets as 'more akin to a gamified fitness app than a full-fledged game.'Verbatim quote confirmed. - #34[confirmed][no action needed]in section: Game Quality and Community Reception
“The team self-reported that Genopets reached one of the top three largest communities on Solana during the private beta period, though independent verification of this claim has not been found.”
reviewerThe team self-reported Genopets reached one of the top three largest communities on Solana during private beta, with independent verification not found.The claim is properly hedged as self-reported and unverified, which matches the actual state of available evidence. - #35[confirmed][no action needed]in section: Game Quality and Community Reception
“Trading volume for GENE has collapsed to under $200 per 24-hour period as of mid-2026, indicating negligible speculative or transactional interest in the token.”
reviewerTrading volume for GENE has collapsed to under $200 per 24-hour period as of mid-2026.Directionally and approximately confirmed; volume remains in the low hundreds of dollars. - #38[confirmed][no action needed]in the timeline
“Genopets raises $8.3 million seed round led by Konvoy Ventures and Pantera Capital; Alameda Research, Mechanism Capital, Animoca Brands among participants.”
reviewerGenopets raised its $8.3 million seed round on October 18, 2021.Confirmed by publication date of the cited article. - #40[confirmed][no action needed]in the timeline
“GENE token reaches all-time high of approximately $37.83.”
reviewerGENE reached an all-time high of approximately $37.83 on November 30, 2021 (timeline entry).Exact match. - #41[confirmed][no action needed]in the timeline
“Samsung Next makes undisclosed post-seed SAFT investment in Genopets.”
reviewerSamsung Next made its undisclosed post-seed SAFT investment in Genopets on July 7, 2022.Minor day-level variance across press pickups is immaterial. - #43[confirmed][no action needed]in the timeline
“FTX and Alameda Research file for bankruptcy; Alameda was a Genopets seed investor.”
reviewerFTX and Alameda Research filed for bankruptcy on November 11, 2022; Alameda was a Genopets seed investor.Widely and independently confirmed. - #44[confirmed][no action needed]in the timeline
“Genopets founders and lead investors agree to extend GENE token vesting by one additional year to a 4-year schedule.”
reviewerGenopets founders and lead investors agreed in December 2022 to extend GENE vesting by one additional year to a 4-year schedule.Directly confirmed by the cited source. - #45[confirmed][no action needed]in the timeline
“Genopets Town Hall outlines 'Genopets Reborn' tokenomics revamp, acknowledging KI inflation and Energy system exploits.”
reviewerA March 8, 2024 Genopets Town Hall outlined the 'Genopets Reborn' tokenomics revamp, acknowledging KI inflation and Energy system exploits.Confirmed by article title and date.
How this fits together. The reviewer reads the published page and its cited sources and records one finding per claim. A human moderator decides whether each proposed correction is applied; those decisions, and the score changes they cause, appear in the audit log. Earlier review runs are not shown here; only the latest reflects the page as it stands.